Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Gemcitabine/Cisplatin in Advanced HCC
NCT00808145Phase 2Withdrawn
- Sponsor
- Lahey Hospital & Medical Center
- Start
- Feb 2009
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, gemcitabine, cisplatin in hepatocellular carcinoma (HCC), sponsored by Lahey Hospital & Medical Center. Planned start Feb 2009; status: withdrawn.
02
Drugs
sorafenibgemcitabinecisplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00808145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808145.